natgillin/translations-raw huggingface dataset:
Pharmacokinetics under the specific study conditions of extended inhalation time, were investigated in a randomised, crossover study with 19 healthy adult men following inhalation of single doses of Ventavis 10 microgram/ml and Ventavis 20 microgram/ml (dose of 5 microgram iloprost at the mouthpiece) using the I-Neb. 
Farmakokinetika u posebnim uvjetima ispitivanja koji su uključivali produljeno trajanje inhalacije ispitana je u randomiziranom križnom ispitivanju na 19 zdravih odraslih muškaraca nakon inhalacije jednokratnih doza lijeka Ventavis 10 mikrograma/ml i Ventavis 20 mikrograma/ml (doza od
The baseline 6-minute walk test values reflected a moderate exercise limitation: in the iloprost group the mean was 332 metres (median value: 340 metres) and in the placebo group the mean was 315 metres (median value: 321 metres). 
Vrijednosti početnog testa 6-minutnog hoda ukazivale su na umjereno ograničenje tjelesnih aktivnosti: u skupini koja je primala iloprost prosjek je iznosio 332 metra (medijan vrijednosti:
Your doctor will supervise your treatment if switching from Ventavis 10 microgram /ml to Ventavis 20 microgram/ml to monitor how well you tolerate the higher concentration. 
Ako ste prebačeni s lijeka Ventavis 10 mikrograma/ml na Ventavis 20 mikrograma/ml, liječnik će nadgledati Vaše liječenje da bi pratio koliko dobro podnosite višu koncentraciju.
Venta-Neb prompts the patient to inhale by an optical and an acoustic signal. 
Venta-Neb bolesniku daje vizualni i zvučni signal za početak inhalacije.
Venta-Neb, a portable ultrasonic battery-powered nebuliser, has also been shown to be suitable for the administration of Ventavis 10 microgram/ml. 
Venta-Neb, prijenosni ultrazvučni nebulizator s baterijskim napajanjem pokazao se prikladnim za primjenu lijeka Ventavis 10 mikrograma/ml.
Newborns, infants and pregnant women should not be in the same room while you are inhaling Ventavis. 
Novorođenčad, dojenčad i trudnice ne smiju biti u istoj prostoriji dok Vi inhalirate Ventavis.
The ampoules containing 2 ml are marked with two coloured rings (white - pink). 
Ampule koje sadrže 2 ml označene su s dva prstena u boji (bijeli - ružičasti).
Since the I-Neb AAD system can be used for Ventavis 10 microgram/ml and Ventavis 20 microgram/ml, the table below provides a summary of the user instructions of the I-Neb for the 2 concentrations of Ventavis: 
Budući da se sustav I-Neb AAD može koristiti s lijekom Ventavis 10 mikrograma/ml i Ventavis 20 mikrograma/ml, donja tablica donosi sažetak uputa za korisnike za I-Neb za obje koncentracije lijeka Ventavis:
In particular, newborns, infants and pregnant women should not be in the same room while you are inhaling Ventavis. 
Osobito, novorođenčad, dojenčad i trudnice ne smiju biti u istoj prostoriji dok inhalirate Ventavis.
Syncope is a common symptom of the disease itself, but can also occur under therapy. 
Sinkopa je čest simptom same bolesti, ali može se pojaviti i tijekom liječenja.
Care should be exercised during initiation of therapy until any effects on the individual have been determined. 
Na početku liječenja, dok se ne ustanove učinci na osobu, potrebno je primjenjivati mjere opreza.
• Ventavis 10 microgram/ml: 
• Ventavis 10 mikrograma/ml:
Venta-Neb, a portable ultrasonic battery-powered nebuliser, has been shown to be suitable for the administration of Ventavis 10 microgram/ml nebuliser solution (2 ml ampoule). 
Venta-Neb, prijenosni ultrazvučni nebulizator s baterijskim napajanjem pokazao se prikladnim za primjenu Ventavis 10 mikrograma/ml otopine za nebulizator (ampula od 2 ml).
At initiation of Ventavis treatment or if the patient is switched from an alternative device, the first inhalation should be made with 1 ml ampoule of Ventavis 10 microgram/ml (see section 4.4). 
Na početku liječenja lijekom Ventavis ili ako bolesnik prelazi s uporabe drugog uređaja na Breelib, prva inhalacija mora se provesti s ampulom od 1 ml lijeka Ventavis 10 mikrograma/ml (vidjeti dio 4.4).
Ventavis 10 microgram/ml nebuliser solution (1 ml ampoule) delivers 2.5 microgram and Ventavis 20 microgram/ml nebuliser solution delivers 5 microgram at the mouthpiece of the Breelib nebuliser. 
Ventavis 10 mikrograma/ml (ampula od 1 ml) otopina za nebulizator isporučuje 2,5 mikrograma, a Ventavis 20 mikrograma/ml otopina za nebulizator isporučuje 5 mikrograma u nastavku za usta Breelib nebulizatora.
How to store Ventavis 
Kako primjenjivati Ventavis
PACK WITH 42 AMPOULES IN A CARTON WITH 168 (4 x 42) AMPOULES WITH 1 ML PACK WITH 42 AMPOULES IN A CARTON WITH 168 (4 x 42) AMPOULES WITH 1 ML CO-PACKED WITH BREELIB CONSUMABLES SET 
PAKIRANJE S 42 AMPULE U KARTONSKOJ KUTIJI SA 168 (4 x 42) AMPULA S 1 ML PAKIRANJE S 42 AMPULE U KARTONSKOJ KUTIJI SA 168 (4 x 42) AMPULA S 1 ML PAKIRANIH ZAJEDNO SA ZAMJENSKIM
• pain when swallowing (pharyngolaryngeal irritation) 
• bol prilikom gutanja (iritacija ždrijela i grkljana)
The measured MMAD of the aerosol droplets was 2.6 micrometres. 
Izmjereni medijan mase aerodinamičkog promjera kapljica aerosola iznosio je 2,6 mikrometara.
SIA Bayer Tel: +371 67 84 55 63 
Tel: +371 67 84 55 63
Symptoms can be flushing or reddening of the face. 
Simptomi mogu biti crvenilo praćeno osjećajem vrućine ili samo crvenilo lica.
For administration with the Venta-Neb. 
Za primjenu pomoću nebulizatora Venta-Neb.
If you tolerate this dose well, your next inhalation will be with Ventavis 20 microgram/ml (ampoule with yellow and red rings). 
Ako dobro podnosite tu dozu, pri sljedećoj inhalaciji ćete uzeti Ventavis od 20 mikrograma/ml (ampula sa žutim i crvenim prstenom).
What Ventavis is used for 
Što je Ventavis i za što se koristi
Since the I-Neb AAD nebuliser can be used for Ventavis 10 microgram/ml and Ventavis 20 microgram/ ml, the table below provides a summary of the user instructions of the I-Neb for the 2 concentrations of Ventavis: 
Budući da se I-Neb AAD nebulizator može koristiti s lijekom Ventavis 10 mikrograma/ml i Ventavis 20 mikrograma/ml, donja tablica prikazuje sažetak uputa za korisnike za I-Neb za obje koncentracije lijeka Ventavis:
Depending on your individual needs, Ventavis can be used for long term treatment. 
Ventavis se može koristiti za dugotrajno liječenje ovisno o Vašim osobnim potrebama.
A mean increase in the 6-minute walk test of 44.7 metres from a baseline mean value of 329 metres vs. a change of -7.4 metres from a baseline mean value of 324 metres in the placebo group (no data imputation for death or missing values) was observed in the subgroup of 49 patients with primary pulmonary hypertension receiving treatment of inhaled iloprost for 12 weeks (46 patients in the placebo group). 
U podskupini od 49 bolesnika s primarnom plućnom hipertenzijom koji su 12 tjedana liječeni inhaliranim iloprostom (46 bolesnika u skupini koja je primala placebo) uočeno je prosječno povećanje rezultata testa 6-minutnog hoda od 44,7 metara u odnosu na početnu prosječnu vrijednost od 329 metara, dok je u skupini koja je primala placebo uočena promjena od -7,4 metara u odnosu na početnu izmjerenu vrijednost od 324 metra (bez korekcije podataka za smrtne ishode ili nedostajuće vrijednosti).
Ventavis 10 microgram/ml is provided in colourless ampoules, containing either 1 ml or 2 ml nebuliser solution. 
Ventavis 10 mikrograma/ml je dostupan u bezbojnim ampulama koje sadrže ili 1 ml ili 2 ml otopine za nebulizator.
Part of a multipack containing 168 (4 x 42) ampoules with 1 ml. 
Dio višestrukog pakiranja koje sadrži 168 (4 x 42) ampula s 1 ml.
For details refer to the instruction manual of the Venta-Neb nebuliser. 
Pojedinosti potražite u uputama za uporabu za nebulizator Venta-Neb.
As you repeatedly experience extended inhalation treatment times with Ventavis 10 microgram/ml (1 ml ampoule with white and yellow rings), your doctor decided to switch to Ventavis 20 microgram/ml. 
Budući da Vam je trajanje inhalacijskog liječenja lijekom Ventavis 10 mikrograma/ml (ampula od 1 ml s bijelim i žutim prstenom) u više navrata bilo produljeno, liječnik Vas je odlučio prebaciti na
No studies to investigate the metabolism of iloprost were performed following inhalation of Ventavis. 
Nakon inhalacije lijeka Ventavis nisu provedena ispitivanja metabolizma iloprosta.
Ventavis is a clear, colourless to slightly yellowish nebuliser solution for inhalation with the Breelib or the I-Neb nebuliser. 
Kako Ventavis izgleda i sadržaj pakiranja: Ventavis je bistra, bezbojna do blago žućkasta otopina za nebulizator namijenjena za inhalaciju pomoću Breelib ili I-Neb nebulizatora.
Peripheral oedema is a very common symptom of the disease itself, but can also occur under therapy. 
Periferni edem vrlo je čest simptom same bolesti, ali može se pojaviti i tijekom liječenja.
• Breelib nebuliser 
• Nebulizator Breelib
If you are starting Ventavis treatment or if you switch from an alternative device your first inhalation will be with Ventavis 10 microgram/ml (1 ml ampoule with white and yellow rings). 
Ako započinjete liječenje lijekom Ventavis ili prelazite s uporabe drugog uređaja Vaša prva inhalacija bit će s lijekom Ventavis od 10 mikrograma/ml (ampula od 1 ml s bijelim i žutim prstenom).
• Ventavis 20 microgram/ml: 
• Ventavis 20 mikrograma/ml:
• For the inhalation you should use a mouthpiece to prevent Ventavis coming into contact with your skin. 
• Kako bi se spriječilo da Ventavis dođe u kontakt s kožom, pri inhalaciji je potrebno koristiti nastavak za usta.
Ventavis 20 microgram/ml is provided in colourless ampoules, containing 1 ml nebuliser solution. 
Ventavis 20 mikrograma/ml je dostupan u bezbojnim ampulama koje sadrže 1 ml otopine za nebulizator.
Ventavis 10 microgram/ml (1 ml ampoule) and Ventavis 20 microgram/ml nebuliser solution 
Ventavis 10 mikrograma/ml (ampula od 1 ml) i Ventavis 20 mikrograma/ml otopina za nebulizator
Ventavis 20 microgram/ml nebuliser solution 5 years. 
Ventavis 20 mikrograma/ml otopina za nebulizator 5 godina.
Multipack: 300 (10 x 30) ampoules with 2 ml. 
Višestruko pakiranje: 300 (10 x 30) ampula s 2 ml.
168 (4 x 42) AMPOULES WITH 1 ML 
168 (4 x 42) AMPULA S 1 ML
No disturbance of post-natal development and reproductive performance was seen in animals exposed during lactation. 
U životinja izloženih lijeku tijekom laktacije nije uočen poremećaj u postnatalnom razvoju i reprodukciji.
This nebuliser monitors the breathing pattern to determine the aerosol pulse time required to deliver the pre-set dose of 2.5 or 5 microgram iloprost. 
Ovim nebulizatorom prati se obrazac disanja kako bi se odredilo vrijeme impulsa za aerosol potrebno za isporuku unaprijed određene doze iloprosta od 2,5 ili 5 mikrograma.
Iloprost may increase the effects of vasodilatators and antihypertensive agents and then favour the risk of hypotension (see section 4.4). 
4.5 Interakcije s drugim lijekovima i drugi oblici interakcija Iloprost može pojačati učinke vazodilatora i antihipertenzivnih lijekova i tako pridonijeti riziku od hipotenzije (vidjeti dio 4.4).
No tumourigenic potential of iloprost was observed in tumourigenicity studies in rats and mice. 
U ispitivanjima tumorogenosti na štakorima i miševima nije uočen tumorogeni potencijal iloprosta.
Dose of iloprost at mouthpiece 
Doza iloprosta u nastavku za usta
The ampoules containing 1 ml are marked with two coloured rings (white - yellow). 
Ampule koje sadrže 1 ml označene su s dva prstena u boji (bijeli - žuti).
Close supervision by the treating physician is necessary if switching from Ventavis 10 microgram/ml to Ventavis 20 microgram/ml to control the acute tolerance relating to faster delivery rate of iloprost with the double concentration. 
Ako se prelazi s lijeka Ventavis 10 mikrograma/ml na Ventavis 20 mikrograma/ml, neophodan je pomni nadzor nadležnog liječnika zbog kontrole akutne podnošljivosti vezano uz bržu primjenu iloprosta pri dvostrukoj koncentraciji.
The pre-set dose provided by the I-Neb AAD nebuliser is controlled by the medication chamber in combination with a control disc. 
Unaprijed određenu dozu koja se primjenjuje putem I-Neb AAD nebulizatora kontrolira komora za lijek u kombinaciji s kontrolnim diskom.
• chest discomfort / chest pain 
• nelagoda/bol u prsnom košu
This nebuliser monitors the breathing pattern to determine the aerosol pulse time required to deliver the pre-set dose of 5 micrograms iloprost of the Ventavis 20 microgram/ml nebuliser solution (1 ml ampoule with yellow and red rings). 
Ovaj nebulizator prati obrazac disanja kako bi se odredilo vrijeme impulsa za aerosol potrebno za isporuku unaprijed određene doze od 5 mikrograma iloprosta iz Ventavis 20 mikrograma/ml otopine za nebulizator
If you tolerate this dose well, your dose should be increased to 5 microgram and you should continue on this dose. 
Ako dobro podnosite tu dozu, Vašu dozu je potrebno povećati na 5 mikrograma i nastaviti s tom dozom.
The ampoules containing 1 ml are marked with two coloured rings (yellow-red). 
Ampule s 1 ml označene su s dva prstena u boji (žuti-crveni).
The pre-set dose provided by the I-Neb AAD system is controlled by the medication chamber in combination with a control disc. 
Dozu koja se primjenjuje putem sustava I-Neb AAD kontrolira komora za lijek u kombinaciji s kontrolnim diskom.
Multipack containing 168 (4x42) ampoules for use with the Breelib and I-Neb nebuliser. 
Višestruko pakiranje sadrži 168 (4x42) ampula za primjenu pomoću nebulizatora Breelib i I-Neb.
Cmax and AUC (0-tlast) after inhalation of 5 microgram iloprost administered as Ventavis 20 microgram/ml using the Breelib were 77% and 42%, respectively higher compared to inhalation of the same dose using Ventavis 10 microgram/ml and the I-Neb AAD system. 
20 mikrograma/ml pomoću nebulizatora Breelib bila je 77%, odnosno 42% veća u usporedbi s inhalacijom iste doze primjenom lijeka Ventavis 10 mikrograma/ml pomoću sustava I-Neb AAD.
Pack containing 30 or 42 ampoules for use with the Breelib and I-Neb nebuliser. 
- Pakiranje s 30 ampula ili 42 ampule za primjenu pomoću nebulizatora Breelib ili I-Neb.
Multipack: 90 (3 x 30) ampoules with 2 ml. 
Višestruko pakiranje: 90 (3 x 30) ampula s 2 ml.
For each inhalation session the content of one opened ampoule of Ventavis has to be transferred completely into the medication chamber immediately before use. 
6.6 Posebne mjere za zbrinjavanje i druga rukovanja lijekom Prilikom svake inhalacije, sadržaj jedne otvorene ampule lijeka Ventavis mora se neposredno prije primjene u potpunosti prenijeti u komoru za lijek.
Package leaflet: Information for the user Ventavis 20 microgram/ml nebuliser solution 
Uputa o lijeku: Informacije za korisnika Ventavis 20 mikrograma/ml otopina za nebulizator iloprost
Ventavis 10 microgram/ml nebuliser solution 4 years. 
Ventavis 10 mikrograma/ml otopina za nebulizator 4 godine.
Bayer d. o. o. Tel.: +386 (0)1 58 14 400 
Tel.: +386 (0)1 58 14 400
This nebuliser monitors the breathing pattern to determine the aerosol pulse time required to deliver the pre-set dose of 5 microgram iloprost. 
Ovim nebulizatorom prati se obrazac disanja da bi se odredilo vrijeme impulsa za aerosol potrebno za isporuku unaprijed određene doze iloprosta od 5 mikrograma.
Nebuliser solution. 
Otopina za nebulizator.
• 90 (3x30) ampoules 
• 90 (3x30) ampula • 300 (10x30) ampula.
Interruption of therapy 
Prekid liječenja
Package leaflet: Information for the user Ventavis 10 microgram/ml nebuliser solution 
Uputa o lijeku: Informacije za korisnika Ventavis 10 mikrograma/ml otopina za nebulizator iloprost
Bayer plc Tel: +44 (0)118 206 3000 
Tel: +44 (0) 118 206 3000
If this dose is well tolerated, dosing should be increased to 5 microgram iloprost using 1 ml ampoule of Ventavis 10 microgram/ml and maintained at that dose. 
Ako se ta doza podnosi dobro, dozu je potrebno povećati i zadržati na dozi s 5 mikrograma iloprosta primjenom ampule od 1 ml lijeka Ventavis 10 mikrograma/ml.
• P1 Programme 1: 5 microgram active substance on the mouth piece 25 inhalation cycles. 
• P1 program 1: 5 mikrograma djelatne tvari u nastavku za usta uz 25 ciklusa inhalacije.
Device 
OBLIK
Using more Ventavis than you should may lead to dizziness, headache, flushing (reddening of the face), nausea (feeling sick), jaw pain or back pain. 
Ako primijenite više lijeka Ventavis nego što ste trebali Uzimanje veće količine lijeka Ventavis od potrebne može dovesti do omaglice, glavobolje, naleta crvenila (crvenilo lica), mučnine, boli u čeljusti ili boli u leđima.
For Ventavis 20 microgram/ml (5 microgram dose), the medication chamber with the golden coloured latch is used together with the golden control disc. 
Za Ventavis 20 mikrograma/ml (doza od 5 mikrograma) koristi se komora za lijek s jezičkom zlatne boje zajedno s kontrolnim diskom zlatne boje.
If you tolerate this dose well, your dose should be increased to 5 microgram iloprost and you should continue on this dose. 
Ako dobro podnosite tu dozu, Vašu dozu je potrebno povećati na 5 mikrograma iloprosta i nastaviti s tom dozom.
The adverse reactions reported below are based on pooled clinical trial data from phase II and III clinical trials involving 131 patients taking the medicinal product and on data from post-marketing surveillance. 
provedenim na 131 bolesniku koji je uzimao lijek i na podacima prikupljenim tijekom praćenja nakon stavljanja lijeka u promet.
In general, when starting Ventavis treatment the first inhaled dose should be 2.5 microgram iloprost as delivered at the mouthpiece. 
Općenito, na početku liječenja lijekom Ventavis, prva doza koja se inhalira mora biti 2,5 mikrograma iloprosta dostavljena putem nastavka za usta.
1 ml solution contains 10 microgram iloprost (as iloprost trometamol). 
1 ml otopine sadrži 10 mikrograma iloprosta (u obliku iloprosttrometamola).
Ventavis 10 microgram/ml; 2 ml 
Ventavis 10 mikrograma/ml; 2 ml
PACK WITH 30 AMPOULES IN A CARTON WITH 90 (3 x 30) AMPOULES WITH 2 ML PACK WITH 30 AMPOULES IN A CARTON WITH 300 (10 x 30) AMPOULES WITH 2 ML 
U KARTONSKOJ KUTIJI S 90 (3 x 30) AMPULA S 2 ML PAKIRANJE S 30 AMPULA
• P2 Programme 2: 2.5 microgram active substance on the mouth piece 10 inhalation cycles. 
• P2 program 2: 2,5 mikrograma djelatne tvari u nastavku za usta uz 10 ciklusa inhalacije.
42 ampoules with 1 ml. 
42 ampule s 1 ml.
Ventavis 10 microgram/ml nebuliser solution (1 ml ampoule) 
Ventavis 10 mikrograma/ml otopina za nebulizator (ampula od 1 ml)
For administration with the Breelib. 
Za primjenu pomoću nebulizatora Breelib.
1 ml solution contains 20 microgram iloprost (as iloprost trometamol). 
1 ml otopine sadrži 20 mikrograma iloprosta (u obliku iloprosttrometamola).
P2 Programme 2: 2.5 microgram active substance on the mouth piece 10 inhalation cycles. 
P2 program 2: 2,5 mikrograma djelatne tvari u nastavku za usta uz 10 ciklusa inhalacije.
For the 2.5 microgram dose of Ventavis 10 microgram/ml the medication chamber with the red coloured latch is used together with the red control disc. 
Za dozu od 2,5 mikrograma lijeka Ventavis 10 mikrograma/ml koristi se komora za lijek s crvenim jezičkom u kombinaciji s crvenim kontrolnim diskom.
Ventavis 20 microgram/ml; 1 ml 
Ventavis 20 mikrograma/ml; 1 ml
• 168 (4x42) ampoules co-packed with Breelib consumables set (containing 1 mouthpiece and 1 
• 168 (4 x 42) ampula pakiranih zajedno sa zamjenskim setom Breelib (sadrži 1 nastavak za usta i
42 AMPOULES WITH 1 ML 
42 ampule s 1 ml
Multipack: 168 (4 x 42) ampoules with 1 ml. 
Višestruko pakiranje:168 (4 x 42) ampula s 1 ml.
Ampoules with 2 ml nebuliser solution (for the use of Venta-Neb): 
Ampule s 2 ml otopine za nebulizator (za primjenu pomoću uređaja Venta-Neb): Pakiranja sadrže:
• 3 ml ampoules, colourless, glass type I, containing 2 ml nebuliser solution, ring coded with two coloured rings (white - pink). 
• ampule od 3 ml, od bezbojnog stakla tipa I, s 2 ml otopine za nebulizator, označene s dva prstena u različitim bojama (bijeli - ružičasti).
Inhalation use. 
Za inhaliranje
• For the 2.5 microgram dose the medication chamber with the red latch is used together with the red control disc. 
• Za dozu od 2,5 mikrograma koristi se komora za lijek s crvenim jezičkom u kombinaciji s crvenim kontrolnim diskom.
Just before you start to inhale, break the glass ampoule containing 2 ml solution, which has two coloured rings (white-pink), and pour the complete contents into the nebuliser medication chamber. 
Neposredno prije početka inhalacije, prelomite staklenu ampulu koja sadrži 2 ml otopine i označena je s dva prstena u boji (bijeli - ružičasti) i sav sadržaj izlijte u komoru za lijek u nebulizatoru.
Ventavis 10 microgram/ml; 1 ml 
Ventavis 10 mikrograma/ml; 1 ml
Part of a multipack containing 168 (4 x 42) ampoules with 1 ml co-packed with Breelib consumables set (containing 1 mouthpiece and 1 medication chamber). 
Dio višestrukog pakiranja koje sadrži 168 (4 x 42) ampula s 1 ml pakiranih zajedno sa zamjenskim setom Breelib (sadrži 1 nastavak za usta i 1 komoru za lijek).
Tel: +420 266 101 111 
Bayer s.r.o. Tel: +420 266 101 111
Just before you start to inhale, break the glass ampoule containing 1 ml solution, which has two coloured rings (white - yellow), and pour the complete contents into the nebuliser medication chamber. 
Neposredno prije početka inhalacije, prelomite staklenu ampulu koja sadrži 1 ml otopine i označena je s dva prstena u boji (bijeli - žuti) i sav njezin sadržaj izlijte u komoru za lijek u nebulizatoru.
90 ampoules with 2 ml. 
90 ampula s 2 ml.
30 ampoules with 2 ml. 
30 ampula s 2 ml.
• nausea 
• kašalj
• or other inhibitors of platelet aggregation, such as acetylsalicylic acid, non-steroidal anti-inflammatory medicinal products, non-selective phosphodiesterase inhibitors like pentoxifylline, selective phosphodiesterase 3 (PDE3) inhibitors like cilostazol or anagrelide, ticlopidine, clopidogrel, glycoprotein IIb/IIIa antagonists, like o abciximab, o eptifibatide, o tirofiban, defibrotide. 
nesteroidne protuupalne lijekove, neselektivne inhibitore fosfodiesteraze, kao što je pentoksifilin, selektivne inhibitore fosfodiesteraze 3 (PDE 3), kao što su cilostazol ili anagrelid,
The I-Neb AAD nebuliser has been shown to be suitable for the administration of Ventavis 10 microgram/ml (1 ml ampoule with white and yellow rings). 
AAD pokazao se prikladnim za primjenu lijeka Ventavis 10 mikrograma/ml (ampula od 1 ml s bijelim i žutim prstenom).
100 ampoules with 2 ml. 
100 ampula s 2 ml.
30 AMPOULES WITH 2 ML 90 AMPOULES WITH 2 ML 90 (3 x 30) AMPOULES WITH 2 ML 100 AMPOULES WITH 2 ML 300 AMPOULES WITH 2 ML 300 (10 x 30) AMPOULES WITH 2 ML 
S 2 ML 90 (3 x 30) AMPULA S 2 ML 100 AMPULA
At initiation of Ventavis treatment with I-Neb system the first inhaled dose should be 2.5 microgram iloprost as delivered at the mouthpiece of the nebuliser using 1 ml ampoule of Ventavis 10 microgram/ml. 
Na početku liječenja lijekom Ventavis s I-Neb sustavom, prva doza koja se inhalira je 2,5 mikrograma iloprosta dostavljena putem nastavka za usta nebulizatora primjenom ampule od 1 ml lijeka Ventavis
Ventavis 20 microgram/ml nebuliser solution 1 ml solution contains 20 microgram iloprost (as iloprost trometamol). 
Ventavis 20 mikrograma/ml otopina za nebulizator 1 ml otopine sadrži 20 mikrograma iloprosta (u obliku iloprosttrometamola).
Dose of iloprost at Estimated inhalation time mouthpiece 
Procijenjeno trajanje inhalacije u nastavku za usta
If you get any side effects talk to your doctor. 
Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti liječnika.
Ventavis 10 microgram/ml nebuliser solution 1 ml solution contains 10 microgram iloprost (as iloprost trometamol). 
Ventavis 10 mikrograma/ml otopina za nebulizator 1 ml otopine sadrži 10 mikrograma iloprosta (u obliku iloprosttrometamola).
• 1 ml ampoules, colourless, glass type I, containing 1 ml nebuliser solution, ring coded with two coloured rings (yellow - red). 
• ampule od 1 ml, od bezbojnog stakla tipa I, s 1 ml otopine za nebulizator, označene s dva prstena u različitim bojama (žuti - crveni).
Each ampoule with 2 ml contains 20 microgram iloprost. 
Svaka ampula s 2 ml otopine sadrži 20 mikrograma iloprosta.
• I-Neb nebuliser 
• Nebulizator I-Neb